Showing 580 – 590 of 1228 results
-
PhaseBio Pharmaceuticals Inc Initiation
William Blair & Company initiated research coverage of PhaseBio Pharmaceuticals, Inc. (PHAS $5.04).
-
Dynatrace Inc Initiation
William Blair & Company initiated research coverage of Dynatrace, Inc. (DT $24.18), which provides a leading software intelligence platform.
-
A Back-to-School Season Like No Other
Online instruction surges amid COVID.
-
Second Quarter Earnings Preview
In this Economics Weekly, we break down the past quarter’s earnings and preview the main factors that we will be looking for from a macro perspective.
-
Hugo Scott-Gall
View the biography for Hugo Scott-Gall, Partner, Portfolio Manager, Co-Director of Research.
-
Michael Pezzuto
View biography for Michael Pezzuto, Senior Wealth Planner.
-
Manny Hodzic
View biography for Manny Hodzic, Wealth Advisor.
-
Madison Wright
View biography for Madison Wright, ESG Integration Lead.
-
David Adams
View biography for David Adams, Partner, Director of Strategy for William Blair Investment Management.
-
The Quarterly Rx Q1 2023 US Biopharma Recap
The year kicked off with renewed optimism for the biopharma sector, but “macro” concerns resurfaced to end the quarter.